Tag Archives: Moderna

CNBC reports: The Food and Drug Administration Wednesday night authorized booster shots of both Johnson & Johnson and Moderna’s Covid vaccines, another critical step in distributing extra doses to tens of millions of people. At the same time, U.S. regulators also authorized “mixing and matching” vaccines, allowing Americans to get a booster shot that’s a different vaccine from the one …

The New York Times reports: The Food and Drug Administration is planning to allow Americans to receive a different Covid-19 vaccine as a booster than the one they initially received, a move that could reduce the appeal of the Johnson & Johnson vaccine and provide flexibility to doctors and other vaccinators. The government would not recommend one shot over another, …

The New York Times reports: A key advisory committee to the Food and Drug Administration voted on Thursday to recommend a booster shot of the Moderna coronavirus vaccine for many of the vaccine’s recipients, at least six months after a second dose. The panel endorsed a half-dose as a third injection for people 65 and older as well as younger …

The New York Times reports: The federal government is expected to take a significant step this week toward offering booster doses to a much wider range of Americans as advisers to the Food and Drug Administration meet on Thursday and Friday to discuss recipients of the Johnson & Johnson and Moderna coronavirus vaccines. On Thursday, the F.D.A.’s advisory panel of …

CNBC reports: Moderna said its Covid-19 vaccine booster shot produced a “robust” antibody response against the highly contagious delta variant, according to details of a study released Thursday with the company’s second-quarter earnings report. In a phase two trial, Moderna is testing a 50-microgram dose of three vaccine booster candidates in previously vaccinated individuals. The booster shots produced a promising …

CNBC reports: Moderna said Tuesday its Covid-19 vaccine was 100% effective in a study of adolescents ages 12 to 17, making it the second shot behind Pfizer’s to demonstrate high efficacy in younger age groups. The company said it plans to ask the Food and Drug Administration to expand the emergency use of its Covid vaccine for teens early next …

CBS News reports: COVID-19 vaccine maker Moderna will make a third booster shot for its two-dose vaccine available to Americans by the fall, CEO Stéphane Bancel said this week. Moderna’s vaccine is more than 90% effective against the coronavirus six months after the second shot, studies show. What remains unclear is how long immunity from the virus lasts. The same …

STAT News reports: A new study suggests the messenger RNA vaccines produced by Moderna and the Pfizer-BioNTech partnership appeared to be 90% effective in preventing Covid-19 infection in a real-world setting. The study was released Monday in Morbidity and Mortality Weekly Report, an online journal published by the Centers for Disease Control and Prevention. The vaccine effectiveness following two doses …

First, a flashback to last year: In April, less than a month after Covid-19 was officially declared a pandemic, Dolly Parton donated $1 million to coronavirus research at Vanderbilt University. More than seven months later, it’s been revealed that the legendary performer’s donation helped fund Moderna’s Covid-19 vaccine. Parton’s name appears in the preliminary report on the vaccine among sponsors …

The Washington Post reports: Moderna said Wednesday that it has manufactured a new version of its coronavirus vaccine that is tailored to quell infection by the variant first identified in South Africa. A small amount of vaccine has been sent to the National Institutes of Health for a trial to determine whether boosting humans with the modified vaccine will stimulate …

Changing America reports: Emerging data from Israel indicates that the vaccines manufactured by Pfizer and BioNTech, as well as Moderna, may be even more effective than previous results from clinical trials suggested. Israel’s Ministry of Health studied more than 700,000 fully inoculated people—meaning those who received two doses of either vaccine—in the country and saw only 0.04 percent contract a …

The New York Times reports: Moderna’s vaccine is effective against new variants of the coronavirus that have emerged in Britain and South Africa, the company announced on Monday. But it appears to be less protective against the variant discovered in South Africa, and so the company is developing a new form of the vaccine that could be used as a …

The Associated Press reports: Workers on Sunday began packaging shipments of the second COVID-19 vaccine authorized in the U.S., a desperately needed boost to efforts to bring the coronavirus pandemic under control. Employees at a factory in the Memphis area were boxing up the vaccine developed by Moderna Inc. and the National Institutes of Health. The much-needed shots are expected …

The Associated Press reports: The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire that the nation is regularly recording more than 3,000 deaths a day. Much-needed doses are set to arrive Monday after the Food and Drug Administration authorized an emergency rollout of the vaccine developed by Moderna Inc. …

Politico reports: The nation’s system for distributing coronavirus vaccines lacks safeguards to ensure the next wave of doses reaches the most critical workers and at-risk patients rather than star athletes or the well-connected. There’s little chance for anyone to jump the line right now while an extremely limited supply of the vaccine is being distributed. But as soon as more …

CNBC reports: An influential Food and Drug Administration advisory panel on Thursday overwhelmingly backed Moderna’s coronavirus vaccine, a key step paving the way to distribute the second Covid-19 vaccine in the United States next week. An emergency use authorization means the FDA will allow some people to receive the vaccine as the agency continues to evaluate data. It isn’t the …

The Washington Post reports: A Food and Drug Administration panel of outside experts is meeting Thursday to review the Moderna coronavirus vaccine. The panel is discussing the vaccine’s safety and efficacy and, if all goes as expected, the shots could get emergency clearance as soon as Friday. The FDA, in a report Tuesday, confirmed that in Moderna’s clinical trial, the …

The Wall Street Journal reports: The Food and Drug Administration said Tuesday that the Covid-19 vaccine developed by Moderna is “highly effective,” suggesting the vaccine could soon be added to the arsenal against the pandemic. Moderna’s documents posted by the FDA included new data suggesting that its vaccine begins to prevent asymptomatic infections after the first dose. The ability of …

Via press release from Moderna: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the U.S. government has exercised its option to purchase an additional 100 million doses of mRNA-1273, Moderna’s COVID-19 vaccine candidate, bringing its confirmed order commitment to 200 million doses. Of …

STAT News reports: Both Pfizer and Moderna, the two major drug manufacturers likely to receive emergency authorizations for a Covid-19 vaccine in the coming weeks, have rejected invitations from President Trump to appear at a White House “Vaccine Summit” on Tuesday, according to two sources familiar with the event’s planning. The Trump administration has openly feuded with Pfizer in recent …